Biocon Limited (NSE: BIOCON)
India
· Delayed Price · Currency is INR
393.55
+5.50 (1.42%)
Jan 23, 2025, 11:50 AM IST
Biocon Employees
Biocon had 16,315 employees as of March 31, 2024. The number of employees decreased by 230 or -1.39% compared to the previous year.
Employees
16,315
Change (1Y)
-230
Growth (1Y)
-1.39%
Revenue / Employee
9.13M INR
Profits / Employee
882.13K INR
Market Cap
475.49B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Sun Pharmaceutical Industries | 43,000 |
Divi's Laboratories | 9,741 |
Cipla | 27,764 |
Mankind Pharma | 19,540 |
Zydus Lifesciences | 26,921 |
Apollo Hospitals Enterprise | 83,147 |
Aurobindo Pharma | 26,015 |
Alkem Laboratories | 17,432 |
Biocon News
- 7 days ago - CCI penalises investment manager of Goldman Sachs AIF for failing to notify Biocon deal - The Times of India
- 7 days ago - Stock Market Update, January 16: BSE and Biocon hit new 52-week highs today - Business Upturn
- 8 days ago - Pharma sector stocks: Biocon (+3.10%), Aurobindo Pharma (+0.48%), Divis Labs (+0.39%) rise; Mankind Pharma (-1.43%) leads losers - Business Upturn
- 10 days ago - Pharma Stocks Today: Biocon surges 4.41%, Mankind Pharma up 1.85%; Glaxo and Abbott India decline - Business Upturn
- 10 days ago - Biocon shares surge nearly 4% as HSBC upgrades to ‘Buy’ - Business Upturn
- 10 days ago - HSBC upgrades Biocon to ‘Buy’, raises target price to ₹430 - Business Upturn
- 11 days ago - Biocon shares surge 4% today; Motilal Oswal upgrades stock to Buy - Business Upturn
- 11 days ago - Pharma stocks: Biocon up 3.84% on US FDA nod for Malaysia unit; Divi’s Lab gains 0.61%, Mankind Pharma slips 3.75%, GlaxoSmithKline drops 2.42% - Business Upturn